Efficacy and Safety of First-Line Treatment Strategies for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

BACKGROUND: Targeted therapies have led to significant improvement in the management and prognosis of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). We performed a network meta-analysis of frontline treatment options of ALK-positive NSCLC to provide clinical guidance....

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ling, Lu, Dafeng, Xia, Yang, Hong, Shaodong, Selvaggi, Giovanni, Stebbing, Justin, Sun, Yilan, Liang, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606689/
https://www.ncbi.nlm.nih.gov/pubmed/34820326
http://dx.doi.org/10.3389/fonc.2021.754768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606689/
https://www.ncbi.nlm.nih.gov/pubmed/34820326
http://dx.doi.org/10.3389/fonc.2021.754768

Ejemplares similares